Wall Street Zen Upgrades Cemex (NYSE:CX) to Buy

Cemex (NYSE:CX - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued to investors on Saturday.

A number of other research analysts also recently issued reports on CX. Royal Bank Of Canada upped their target price on shares of Cemex from $5.00 to $5.25 and gave the company an "underperform" rating in a research report on Tuesday, April 29th. Bradesco Corretora set a $7.50 target price on shares of Cemex and gave the stock a "neutral" rating in a report on Tuesday, April 15th. JPMorgan Chase & Co. upped their target price on shares of Cemex from $6.00 to $6.80 and gave the company a "neutral" rating in a research report on Tuesday, April 29th. Morgan Stanley lowered Cemex from an "overweight" rating to an "equal weight" rating in a research report on Wednesday, March 26th. Finally, Itau BBA Securities lowered Cemex from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 3rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, Cemex currently has an average rating of "Hold" and a consensus target price of $7.58.

Cemex Price Performance

Shares of CX stock opened at $7.39 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.60 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $10.71 billion, a price-to-earnings ratio of 7.70, a PEG ratio of 1.23 and a beta of 1.38. The firm's 50 day moving average is $6.89 and its 200-day moving average is $6.23. Cemex has a 1 year low of $4.89 and a 1 year high of $7.50.

Cemex (NYSE:CX - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The construction company reported $0.08 EPS for the quarter. The firm had revenue of $186.46 million for the quarter, compared to analyst estimates of $214.59 million. Cemex had a return on equity of 6.47% and a net margin of 8.84%. Sell-side analysts forecast that Cemex will post 0.69 EPS for the current fiscal year.

Institutional Investors Weigh In On Cemex

Several large investors have recently modified their holdings of CX. Wayfinding Financial LLC acquired a new position in shares of Cemex in the 1st quarter valued at approximately $29,000. Farther Finance Advisors LLC lifted its stake in Cemex by 63.7% in the second quarter. Farther Finance Advisors LLC now owns 5,210 shares of the construction company's stock valued at $36,000 after buying an additional 2,027 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Cemex by 334.7% in the first quarter. Jones Financial Companies Lllp now owns 9,189 shares of the construction company's stock valued at $52,000 after buying an additional 7,075 shares during the period. Barclays PLC increased its position in shares of Cemex by 56.2% during the fourth quarter. Barclays PLC now owns 9,759 shares of the construction company's stock worth $55,000 after acquiring an additional 3,510 shares in the last quarter. Finally, Townsquare Capital LLC acquired a new stake in shares of Cemex during the fourth quarter worth $57,000. 82.97% of the stock is currently owned by institutional investors.

Cemex Company Profile

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. The company offers gray ordinary portland, white portland, oil-well, and blended cement products; mortar; and standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.